Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients
The Effects on Fluid Balance and Renal Function Using a Restrictive Fluid Strategy in the Postoperative Setting in Patients With Low Urinary Output Undergoing Pancreatic Surgery
Sponsor: Uppsala University
Terminated
Stopped after interim analysis
Other terminated trials from Uppsala University
Listed as NCT03553394, this NA trial focuses on Fluid Overload and Fluid Therapy and remains terminated or withdrawn. Sponsored by Uppsala University, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Oct 2021 — Nov 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Jun 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Uppsala University
For direct contact, visit the study record on ClinicalTrials.gov .